Phibro Animal Health Corporation re-affirmed earnings guidance for the fiscal year 2022. Looking at net sales, again, up to $890 million to $920 million as guidance.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.47 USD | -0.40% | -1.52% | +50.86% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+50.86% | 710M | |
-13.41% | 76.65B | |
+20.60% | 8.82B | |
+22.25% | 3.6B | |
+14.02% | 1.65B | |
-7.03% | 1.22B | |
-30.92% | 1.11B | |
-34.32% | 1.08B | |
-25.17% | 948M | |
-1.90% | 936M |
- Stock Market
- Equities
- PAHC Stock
- News Phibro Animal Health Corporation
- Phibro Animal Health Corporation Re-Affirms Earnings Guidance for the Fiscal Year 2022